Pediatrics

⚠️ Adverse Drug Reactions and Contraindications

A Comprehensive Article

Amos Asamoah
October 2025
5 min read
Pediatric Pharmacology

Every medication has the potential to cause harm alongside its healing benefits. In children, whose bodies are still developing, recognizing and preventing adverse drug reactions isn't just important—it's a matter of life and death.

📊 Type A Reactions: The Predictable Dangers

📊 Dose-Dependent and Predictable

Type A reactions account for the majority of adverse drug events and are directly related to the medication's pharmacological properties.

Common Type A Reactions

  • Anticholinergic effects: Dry mouth, constipation, urinary retention
  • Sedation: Antihistamines, opioids, benzodiazepines
  • GI upset: NSAIDs, antibiotics, iron supplements
  • Hypotension: Antihypertensives, alpha-blockers
  • Bleeding: Anticoagulants, antiplatelets

Pediatric-Specific Concerns

  • Growth suppression: Chronic corticosteroid use
  • Tooth discoloration: Tetracyclines in children <8 years
  • Appetite suppression: Stimulant medications for ADHD
  • Sleep disturbances: Various CNS-active medications
High-yield: Type A reactions are often manageable through dose adjustment, timing changes, or supportive care.
Prevention strategy: Start low and go slow with medications that have narrow therapeutic windows or significant side effect profiles.

🎲 Type B Reactions: The Unpredictable Dangers

🎲 Idiosyncratic and Unpredictable

These reactions are not dose-related and often involve immune mechanisms or genetic predispositions.

Hypersensitivity Reactions

  • Type I (Immediate): Anaphylaxis, urticaria, angioedema
  • Type II (Cytotoxic): Hemolytic anemia, thrombocytopenia
  • Type III (Immune complex): Serum sickness, vasculitis
  • Type IV (Delayed): Contact dermatitis, SJS/TEN

Other Type B Reactions

  • Drug fever: Antibiotics, anticonvulsants
  • Idiosyncratic hepatotoxicity: Valproate, isoniazid
  • Photosensitivity: Tetracyclines, sulfonamides
  • Pseudomembranous colitis: Clindamycin, broad-spectrum antibiotics
EMERGENCY RECOGNITION: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) begin with fever, malaise, and painful skin lesions that progress to widespread blistering and sloughing. Stop the causative drug immediately!

💀 Severe and Life-Threatening Reactions

💀 When Medications Turn Deadly

Some adverse reactions require immediate recognition and intervention to prevent fatal outcomes.

Anaphylaxis

  • Onset: Minutes to hours after exposure
  • Signs: Difficulty breathing, swelling, hives, hypotension
  • Common triggers: Antibiotics, NSAIDs, vaccines
  • Treatment: Epinephrine, corticosteroids, antihistamines

Serotonin Syndrome

  • Causes: SSRIs, SNRIs, tramadol, linezolid combinations
  • Triad: Mental status changes, autonomic hyperactivity, neuromuscular abnormalities
  • Treatment: Stop causative agents, supportive care, cyproheptadine

Neuroleptic Malignant Syndrome

  • Causes: Antipsychotics, antiemetics
  • Features: Fever, muscle rigidity, altered mental status, autonomic instability
  • Treatment: Stop causative drug, dantrolene, bromocriptine

QT Prolongation & Torsades

  • Drugs: Macrolides, antipsychotics, antiarrhythmics
  • Risk factors: Electrolyte abnormalities, congenital long QT
  • Monitoring: ECG before and during treatment with high-risk drugs

🚫 Absolute Contraindications: The Never-Use Scenarios

🚫 When the Risk Always Outweighs the Benefit

Some medication scenarios are so dangerous they should never be prescribed.

🆘 ABSOLUTE CONTRAINDICATIONS IN PEDIATRICS

  • Aspirin in viral illnesses: Risk of Reye's syndrome in children with viral infections
  • Tetracyclines in children <8 years: Permanent tooth discoloration and enamel hypoplasia
  • Fluoroquinolones in children: Risk of arthropathy and tendon damage (relative contraindication)
  • Codeine in children <12 years: Risk of respiratory depression due to variable metabolism
  • Chloramphenicol in neonates: Gray baby syndrome due to immature metabolism
  • Live vaccines in immunocompromised: Risk of vaccine-strain infection
Black Box Warning: Antidepressants in children and adolescents carry increased risk of suicidal thinking and behavior—requires close monitoring especially during initiation and dose changes.

👁️ Monitoring and Early Detection

👁️ The Art of Vigilance

Proactive monitoring can catch adverse reactions early, before they become severe.

Baseline Assessment — Document pre-existing conditions, allergies, and baseline laboratory values
Regular Follow-up — Schedule appropriate intervals for monitoring based on medication risk
Laboratory Monitoring — CBC, liver function, renal function, therapeutic drug levels as indicated
Clinical Assessment — Growth parameters, vital signs, physical examination findings
Patient/Caregiver Education — Teach recognition of early warning signs
Monitoring schedule: High-risk medications require more frequent monitoring—sometimes weekly initially, then monthly once stable.

🛡️ Prevention Strategies

🛡️ Building Multiple Layers of Safety

Preventing adverse drug reactions requires systematic approaches at every level of medication use.

Prescriber Strategies

  • Know contraindications and black box warnings
  • Use the lowest effective dose for shortest duration
  • Consider drug interactions before prescribing
  • Document allergy history thoroughly
  • Use age-appropriate formulations

System Strategies

  • Electronic health record alerts for allergies
  • Computerized physician order entry with decision support
  • Pharmacist review of high-risk medications
  • Standardized monitoring protocols
  • Medication reconciliation at all transitions of care

🔑 High-Yield ADR Summary Table

Reaction Type Characteristics Examples Management
Type A Predictable, dose-related Sedation from antihistamines, GI upset from NSAIDs Dose reduction, timing changes
Type B Unpredictable, idiosyncratic Anaphylaxis, SJS, drug fever Drug discontinuation, supportive care
Severe Life-threatening Anaphylaxis, serotonin syndrome, NMS Emergency intervention, hospitalization

🎯 Key Takeaways

  • Type A reactions are predictable and dose-dependent—manage with dose adjustment
  • Type B reactions are unpredictable and often immune-mediated—require drug discontinuation
  • Severe reactions like anaphylaxis, SJS, and serotonin syndrome require immediate recognition and treatment
  • Absolute contraindications exist for certain drugs in specific pediatric populations
  • Proactive monitoring can detect adverse reactions early and prevent serious harm
  • Prevention requires multiple layers of safety including prescriber awareness and system safeguards
  • Black box warnings highlight medications with serious or life-threatening risks
  • Patient and caregiver education is essential for early recognition of adverse effects

🌟 The Balance of Benefit and Risk

Prescribing medications to children is always a delicate balance between potential benefit and potential harm. While we cannot eliminate all risk, we can practice with vigilance, knowledge, and systematic safety measures that protect our most vulnerable patients.

The most dangerous prescription is one written without awareness of its potential for harm. By understanding adverse drug reactions and contraindications, we transform from mere prescribers to guardians of pediatric health, ensuring that our treatments help far more than they harm.

Safety First Mandate: In pediatric pharmacology, our first duty is not to treat, but to do no harm. Every prescription must pass through this filter of safety before reaching a child.

← Previous Topic: Common Medications and Safety Concerns Next Topic: Importance of Adherence and Parental Education →